The branding effort, now two years old, is designed to make Cymbalta a household name on par with Prozac, an older antidepressant and Lilly’s top-selling drug before its patent expired in 2001. During an earnings call last week with investors, Lilly executives said Cymbalta is continuing to gain market share and showing “favorable trends” in customer perception. The company launched the brand portion of the campaign in April 2006, introducing viewers to Cymbalta as the answer to depression and its related aches and pains. Along with the marketing blitz, Lilly credits the sales success of Cymbalta to a reorganization of its sales forces, its success in getting the drug recommended by more health- benefits companies, and a direct pitch to primary-care doctors for some uses. read more
Technorati Tags: cymbalta, lilly, depression, 149, campaign, drug, anxiety disorder news
This entry was posted
on Sunday, July 29th, 2007 at 2:37 pm and is filed under Anxiety Disorder News.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.